A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023.

Saved in:
Bibliographic Details
Title: A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023.
Authors: Oh DY; Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute, Berlin, Germany. OhD@rki.de., Hölzer M; Genome Competence Center (MF1), Robert Koch Institute, Berlin, Germany., Börnigen D; Systems medicine of infectious diseases (P5), Robert Koch Institute, Berlin, Germany., Paraskevopoulou S; Genome Competence Center (MF1), Robert Koch Institute, Berlin, Germany., Duwe S; Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute, Berlin, Germany., Budt M; Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute, Berlin, Germany., Kerber R; Respiratory Infections (FG36), Robert Koch Institute, Berlin, Germany., Mikolajewska A; Strategy and Incident Response (ZBS7), Robert Koch Institute, Berlin, Germany., Böttcher S; Gastroenteritis and Hepatitis Pathogens and Enteroviruses (FG15), Robert Koch Institute, Berlin, Germany., Seifried J; Infectious Disease Epidemiology (Dept. 3), Robert Koch Institute, Berlin, Germany., Haas W; Respiratory Infections (FG36), Robert Koch Institute, Berlin, Germany., Dürrwald R; Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute, Berlin, Germany., Fuchs S; Genome Competence Center (MF1), Robert Koch Institute, Berlin, Germany., Kröger S; Respiratory Infections (FG36), Robert Koch Institute, Berlin, Germany., von Kleist M; Systems medicine of infectious diseases (P5), Robert Koch Institute, Berlin, Germany.; Department of Mathematics and Computer Science, Freie Universität Berlin, Berlin, Germany., Wolff T; Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute, Berlin, Germany., Mielke M; Infectious Diseases (Dept. 1), Robert Koch Institute, Berlin, Germany.
Corporate Authors: SARS-CoV-2 Diagnostics and Evolution Working Group at Robert Koch Institute
Source: Communications medicine [Commun Med (Lond)] 2025 Nov 11; Vol. 5 (1), pp. 468. Date of Electronic Publication: 2025 Nov 11.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2730-664X
DOI:10.1038/s43856-025-01093-1